Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net Income (Loss)	$ 297,716	$ 340,437	$ 86,759
Adjustments to reconcile net income to net cash provided by operation activities -
Depreciation, depletion, and amortization	219,116	133,982	68,629
Accretion of asset retirement obligation	985	534	306
Deferred income taxes	83,086	9,625	6,212
Stock-based compensation expense	5,526	5,086	4,645
Gain (Loss) on Sale of Derivatives	(241,309)	73,885	123,018
Cash Received (Paid) On Settlements of Derivative Contracts	88,679	(219,626)	(70,582)
Asset Retirement Obligation, Cash Paid to Settle	(716)	(48)	(158)
Write off of Deferred Debt Issuance Cost	1,239	350	229
Other Noncash Income (Expense)	3,528	3,010	2,877
Change in assets and liabilities-
(Increase) decrease in accounts receivable and other assets	(25,439)	(29,522)	(23,513)
Increase (decrease) in accounts payable and accrued liabilities	7,172	11,788	17,507
Increase (decrease) in income taxes payable	(525)	229	(83)
Increase (decrease) in accrued interest	7,003	1,969	(286)
Net Cash Provided by Operating Activities	447,111	331,241	215,726
Cash Flows from Investing Activities:
Additions to property and equipment	(421,273)	(272,443)	(133,638)
Acquisition of properties	(604,955)	(367,024)	(51,734)
Proceeds from Sale of Property, Plant, and Equipment	(713)	(4,347)	0
Payments for (Proceeds from) Other Investing Activities	0	(750)	(1,084)
Net Cash Used in Investing Activities	(1,025,515)	(635,870)	(186,456)
Cash Flows from Financing Activities:
Proceeds from long-term debt	356,965	0	0
Payments of long-term debt	(14,250)	0	(50,000)
Proceeds from bank borrowings	672,000	841,000	335,000
Payments of bank borrowings	(492,000)	(526,000)	(338,000)
Proceeds from Issuance of Common Stock	97,309	0	26,956
Proceeds from Stock Options Exercised	0	39	0
Purchase of treasury shares	(3,083)	(3,397)	(612)
Payments of debt issuance costs	(30,600)	(7,342)	(3,611)
Net Cash Provided by (Used in) Financing Activities	586,341	304,300	(30,267)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	7,937	(329)	(997)
Total Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	8,729	792	1,121
Supplemental Disclosures of Cash Flows Information:
Cash paid during period for interest, net of amounts capitalized	68,116	36,994	27,221
Increase (decrease) in accrued payables for capital	(13,679)	54,372	(4,033)
Other Significant Noncash Transaction, Value of Consideration Given	0	(156,252)	(83,522)
Non-cash deferred consideration for acquisitions	(50,000)	0	0
Non-cash contingent consideration for acquisitions	$ (16,933)	$ 0	$ 0